As we consider what may lie ahead for markets, income-minded investors can consider the dividend landscape and dividend growth exchange traded fund strategies that have exhibited strong performance characteristics under a wide range of market conditions. In the recent webcast, Investing After the Election: What Experts See for the Road Ahead, Ed Clissold, Chief U.S. [...] Read more at ETFtrends.com.
The total number of coronavirus cases has crossed the grim mark of 50 million. Notably, the world’s largest economy has seen more than 10 million cases alone. The worsening coronavirus crisis is therefore increasing desperation among investors over the introduction of a vaccine
Wall Street spiked on Nov 9 on news that a Pfizer PFE and BioNTech (BNTX) vaccine candidate was more than 90% effective in avoiding COVID-19 in its clinical trial. The vaccine is the first to be tested in the United States to generate late-stage data. Before this, the global mark
Wall Street has been charged up since election. Now, the Nov 9 news that a Pfizer PFE and BioNTech BNTX vaccine candidate was more than 90% effective in avoiding COVID-19 in its clinical trial has instilled more optimism in the markets.
Market optimism was abound during Monday’s trading session as ETF investors were awash in mostly green with the major indexes rallying off vaccine news. If the rally is real, than investors will want to get exposure to names like Pfizer and Moderna, which they can achieve with these five Invesco ETFs. Invesco S&P 500 Top [...] Read more at ETFtrends.com.
Stocks and index ETFs are mixed to lower on Tuesday, as Big Tech gets hit by a market rotation from shares that thrived during the pandemic into stocks deemed to benefit from economic recovery, after ebullience over a potential vaccine on Monday. The S&P 500 lost 0.9% Tuesday, after notching fresh all-time highs on Monday, [...] Read more at ETFtrends.com.
The U.S. economy added 638,000 jobs in October 2020, easing from an upwardly revised 672,000 in the previous month. However, the reading beat market expectations of an increase of 600,000, per tradingeconomics. Still, it was the smallest employment gain since the job market start
Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with AECOM (Symbol: ACM). The average 12-month price target for ACM — averaging the work of 6 analysts — reveals an average price target of $46.00/share. That's
In recent trading, shares of Zions Bancorporation, N.A. (Symbol: ZION) have crossed above the average analyst 12-month target price of $35.97, changing hands for $39.58/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgr
In recent trading, shares of DENTSPLY SIRONA Inc (Symbol: XRAY) have crossed above the average analyst 12-month target price of $50.20, changing hands for $51.40/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on
The Vanguard Communication Services ETF is seeing unusually high volume in afternoon trading Tuesday, with over 925,000 shares traded versus three month average volume of about 195,000. Shares of VOX were down about 1% on the day.
In trading on Tuesday, the iShares U.S. Home Construction ETF is outperforming other ETFs, up about 3.9% on the day. Components of that ETF showing particular strength include shares of Installed Building Products, up about 11.3% and shares of Green Brick Partners, up about 8%
In recent trading, shares of WSFS Financial Corp (Symbol: WSFS) have crossed above the average analyst 12-month target price of $36.00, changing hands for $37.45/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on
In recent trading, shares of United Community Banks Inc (Symbol: UCBI) have crossed above the average analyst 12-month target price of $24.93, changing hands for $25.10/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downg
In recent trading, shares of Trip.com Group Ltd (Symbol: TCOM) have crossed above the average analyst 12-month target price of $35.04, changing hands for $36.57/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v
In recent trading, shares of Stoke Therapeutics Inc (Symbol: STOK) have crossed above the average analyst 12-month target price of $41.25, changing hands for $42.52/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade
In recent trading, shares of Starbucks Corp. (Symbol: SBUX) have crossed above the average analyst 12-month target price of $91.42, changing hands for $95.88/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valu
In recent trading, shares of Sabra Health Care REIT Inc (Symbol: SBRA) have crossed above the average analyst 12-month target price of $15.77, changing hands for $16.00/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgr
In recent trading, shares of Ross Stores Inc (Symbol: ROST) have crossed above the average analyst 12-month target price of $106.35, changing hands for $107.71/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on va
In recent trading, shares of Renasant Corp (Symbol: RNST) have crossed above the average analyst 12-month target price of $28.67, changing hands for $32.36/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuat
BNK Invest
Checked
18 minutes 19 seconds ago
This feed is responsible for generating the rss feed related to the topic ETFs